Large Scale Genomic Instability as an Additive Prognostic Marker in Early Prostate Cancer

Background: The clinical outcome for the individual prostate cancer patient is often difficult to predict, due to lack of reliable independent prognostic biomarkers. We tested DNA ploidy as a prognostic factor for clinical outcome in 186 patients treated with radical prostatectomy.

Saved in:
Bibliographic Details
Main Authors: Maria E. Pretorius, Håkon Wæhre, Vera M. Abeler, Ben Davidson, Ljiljana Vlatkovic, Ragnhild A. Lothe, Karl-Erik Giercksky, Håvard E. Danielsen
Format: Article
Language:English
Published: Wiley 2009-01-01
Series:Cellular Oncology
Online Access:http://dx.doi.org/10.3233/CLO-2009-0463
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832563794382946304
author Maria E. Pretorius
Håkon Wæhre
Vera M. Abeler
Ben Davidson
Ljiljana Vlatkovic
Ragnhild A. Lothe
Karl-Erik Giercksky
Håvard E. Danielsen
author_facet Maria E. Pretorius
Håkon Wæhre
Vera M. Abeler
Ben Davidson
Ljiljana Vlatkovic
Ragnhild A. Lothe
Karl-Erik Giercksky
Håvard E. Danielsen
author_sort Maria E. Pretorius
collection DOAJ
description Background: The clinical outcome for the individual prostate cancer patient is often difficult to predict, due to lack of reliable independent prognostic biomarkers. We tested DNA ploidy as a prognostic factor for clinical outcome in 186 patients treated with radical prostatectomy.
format Article
id doaj-art-981d07d6204340ae9e94dc12bd59c91a
institution Kabale University
issn 1570-5870
1875-8606
language English
publishDate 2009-01-01
publisher Wiley
record_format Article
series Cellular Oncology
spelling doaj-art-981d07d6204340ae9e94dc12bd59c91a2025-02-03T01:12:36ZengWileyCellular Oncology1570-58701875-86062009-01-0131425125910.3233/CLO-2009-0463Large Scale Genomic Instability as an Additive Prognostic Marker in Early Prostate CancerMaria E. Pretorius0Håkon Wæhre1Vera M. Abeler2Ben Davidson3Ljiljana Vlatkovic4Ragnhild A. Lothe5Karl-Erik Giercksky6Håvard E. Danielsen7Institute for Medical Informatics, Rikshospitalet University Hospital, Oslo, NorwayInstitute for Medical Informatics, Rikshospitalet University Hospital, Oslo, NorwayDivision of Pathology, Rikshospitalet University Hospital, Oslo, NorwayDivision of Pathology, Rikshospitalet University Hospital, Oslo, NorwayDivision of Pathology, Rikshospitalet University Hospital, Oslo, NorwayCentre for Cancer Biomedicine, University of Oslo, Oslo, NorwayDivision of Surgery, Rikshospitalet University Hospital, Oslo, NorwayInstitute for Medical Informatics, Rikshospitalet University Hospital, Oslo, NorwayBackground: The clinical outcome for the individual prostate cancer patient is often difficult to predict, due to lack of reliable independent prognostic biomarkers. We tested DNA ploidy as a prognostic factor for clinical outcome in 186 patients treated with radical prostatectomy.http://dx.doi.org/10.3233/CLO-2009-0463
spellingShingle Maria E. Pretorius
Håkon Wæhre
Vera M. Abeler
Ben Davidson
Ljiljana Vlatkovic
Ragnhild A. Lothe
Karl-Erik Giercksky
Håvard E. Danielsen
Large Scale Genomic Instability as an Additive Prognostic Marker in Early Prostate Cancer
Cellular Oncology
title Large Scale Genomic Instability as an Additive Prognostic Marker in Early Prostate Cancer
title_full Large Scale Genomic Instability as an Additive Prognostic Marker in Early Prostate Cancer
title_fullStr Large Scale Genomic Instability as an Additive Prognostic Marker in Early Prostate Cancer
title_full_unstemmed Large Scale Genomic Instability as an Additive Prognostic Marker in Early Prostate Cancer
title_short Large Scale Genomic Instability as an Additive Prognostic Marker in Early Prostate Cancer
title_sort large scale genomic instability as an additive prognostic marker in early prostate cancer
url http://dx.doi.org/10.3233/CLO-2009-0463
work_keys_str_mv AT mariaepretorius largescalegenomicinstabilityasanadditiveprognosticmarkerinearlyprostatecancer
AT hakonwæhre largescalegenomicinstabilityasanadditiveprognosticmarkerinearlyprostatecancer
AT veramabeler largescalegenomicinstabilityasanadditiveprognosticmarkerinearlyprostatecancer
AT bendavidson largescalegenomicinstabilityasanadditiveprognosticmarkerinearlyprostatecancer
AT ljiljanavlatkovic largescalegenomicinstabilityasanadditiveprognosticmarkerinearlyprostatecancer
AT ragnhildalothe largescalegenomicinstabilityasanadditiveprognosticmarkerinearlyprostatecancer
AT karlerikgiercksky largescalegenomicinstabilityasanadditiveprognosticmarkerinearlyprostatecancer
AT havardedanielsen largescalegenomicinstabilityasanadditiveprognosticmarkerinearlyprostatecancer